Corinna Pade
Overview
Explore the profile of Corinna Pade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
1501
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chambers E, Cai W, Vivaldi G, Jolliffe D, Perdek N, Li W, et al.
NPJ Vaccines
. 2024 May;
9(1):87.
PMID: 38778017
Vaccine development targeting SARS-CoV-2 in 2020 was of critical importance in reducing COVID-19 severity and mortality. In the U.K. during the initial roll-out most individuals either received two doses of...
2.
Griffith S, Muir L, Suchanek O, Hope J, Pade C, Gibbons J, et al.
bioRxiv
. 2024 Feb;
PMID: 38370662
Immunological determinants favouring emergence of broadly neutralising antibodies are crucial to the development of HIV-1 vaccination strategies. Here, we combined RNAseq and B cell cloning approaches to isolate a broadly...
3.
Abhishek A, Peckham N, Pade C, Gibbons J, Cureton L, Francis A, et al.
Lancet Rheumatol
. 2024 Jan;
6(2):e92-e104.
PMID: 38267107
Background: Methotrexate is the first-line treatment for immune-mediated inflammatory diseases and reduces vaccine-induced immunity. We evaluated if a 2-week interruption of methotrexate treatment immediately after COVID-19 booster vaccination improved antibody...
4.
Miyashita L, Foley G, Semple S, Gibbons J, Pade C, McKnight A, et al.
J Allergy Clin Immunol Glob
. 2023 Oct;
2(4):100141.
PMID: 37781647
Background: Biologic plausibility for the association between exposure to particulate matter (PM) less than 10 μm in aerodynamic diameter (PM) and coronavirus disease 2019 (COVID-19) morbidity in epidemiologic studies has...
5.
Altmann D, Reynolds C, Joy G, Otter A, Gibbons J, Pade C, et al.
Nat Commun
. 2023 Aug;
14(1):5139.
PMID: 37612310
Among the unknowns in decoding the pathogenesis of SARS-CoV-2 persistent symptoms in Long Covid is whether there is a contributory role of abnormal immunity during acute infection. It has been...
6.
Gokani B, Sacoor S, Leisegang G, Ogunkolade W, Bibi A, Grigoriadou S, et al.
Clin Immunol
. 2023 Jul;
255:109700.
PMID: 37482118
Immune hyperstimulation by SARS-CoV2 results in multi-system involvement with consequent organ damage not dissimilar to Behçet's Disease (BD). Management of BD includes immunosuppressive medication, which led to concerns that; firstly,...
7.
Milighetti M, Peng Y, Tan C, Mark M, Nageswaran G, Byrne S, et al.
iScience
. 2023 Jun;
26(6):106937.
PMID: 37275518
T cell responses precede antibody and may provide early control of infection. We analyzed the clonal basis of this rapid response following SARS-COV-2 infection. We applied T cell receptor (TCR)...
8.
Milojkovic D, Reynolds C, Munoz Sandoval D, Pieper F, Liu S, Pade C, et al.
Leukemia
. 2022 Dec;
37(1):244-247.
PMID: 36528708
No abstract available.
9.
Jolliffe D, Vivaldi G, Chambers E, Cai W, Li W, Faustini S, et al.
Nutrients
. 2022 Sep;
14(18).
PMID: 36145196
Vitamin D deficiency has been reported to associate with the impaired development of antigen-specific responses following vaccination. We aimed to determine whether vitamin D supplements might boost the immunogenicity and...
10.
Doykov I, Baldwin T, Spiewak J, Gilmour K, Gibbons J, Pade C, et al.
Cell Rep Methods
. 2022 Aug;
2(9):100279.
PMID: 35975199
Determining the protection an individual has to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VoCs) is crucial for future immune surveillance, vaccine development, and understanding of the changing...